Brief: Metsera Says Pfizer to Buy Metsera For Up To $86.25 Per Share

Nov 7 (Reuters) - Metsera Inc MTSR.O:

PFIZER AND METSERA ENTER INTO MERGER AGREEMENT AMENDMENT; METSERA'S BOARD OF DIRECTORS REAFFIRMS SUPPORT OF MERGER WITH PFIZER

METSERA INC - REVISED DEAL VALUES METSERA AT UP TO $86.25 PER SHARE

METSERA INC - PFIZER TO BUY METSERA FOR $65.60 CASH PLUS CVR UP TO $20.65

METSERA INC: UNANIMOUSLY RECOMMENDS THAT METSERA STOCKHOLDERS APPROVE ADOPTION OF AMENDED PFIZER MERGER AGREEMENT AND APPROVE MERGER WITH PFIZER

METSERA INC: DETERMINED THAT TRANSACTION PROPOSED BY NOVO NORDISK PRESENTS UNACCEPTABLY HIGH LEGAL AND REGULATORY RISKS TO METSERA & ITS STOCKHOLDERS

:PFIZER AND METSERA ENTER INTO MERGER AGREEMENT AMENDMENT; METSERA'S BOARD OF DIRECTORS REAFFIRMS SUPPORT OF MERGER WITH PFIZER

Source text: ID:nPn5hvQg1a

Further company coverage: MTSR.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Metsera

See all news